98 related articles for article (PubMed ID: 25056130)
41. Characterization and in vitro activity of a branched peptide boronic acid that interacts with HIV-1 RRE RNA.
Wynn JE; Zhang W; Tebit DM; Gray LR; Hammarskjold ML; Rekosh D; Santos WL
Bioorg Med Chem; 2016 Sep; 24(17):3947-3952. PubMed ID: 27091070
[TBL] [Abstract][Full Text] [Related]
42. Design of antiviral stapled peptides containing a biphenyl cross-linker.
Muppidi A; Zhang H; Curreli F; Li N; Debnath AK; Lin Q
Bioorg Med Chem Lett; 2014 Apr; 24(7):1748-51. PubMed ID: 24613163
[TBL] [Abstract][Full Text] [Related]
43. HIV-1 inhibiting capacity of novel forms of presentation of GB virus C peptide domains is enhanced by coordination to gold compounds.
Gómara MJ; Galatola R; Gutiérrez A; Gimeno MC; Gatell JM; Sánchez-Merino V; Yuste E; Haro I
Curr Med Chem; 2014; 21(2):238-50. PubMed ID: 24083612
[TBL] [Abstract][Full Text] [Related]
44. Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replication.
Shkreta L; Blanchette M; Toutant J; Wilhelm E; Bell B; Story BA; Balachandran A; Cochrane A; Cheung PK; Harrigan PR; Grierson DS; Chabot B
Nucleic Acids Res; 2017 Apr; 45(7):4051-4067. PubMed ID: 27928057
[TBL] [Abstract][Full Text] [Related]
45. Anti-HIV-1 activity determined by β-galactosidase activity in the multinuclear activation of an indicator assay is comparable with that by a conventional focus counting method.
Miyamoto F; Kawaji K; Oishi S; Fujii N; Kaku M; Kodama EN
Antivir Chem Chemother; 2015 Apr; 24(2):77-82. PubMed ID: 26527820
[TBL] [Abstract][Full Text] [Related]
46. Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides.
Chandra K; Maes M; Friedler A
Future Med Chem; 2015; 7(8):1055-77. PubMed ID: 26062401
[TBL] [Abstract][Full Text] [Related]
47. Multimeric Amphipathic α-Helical Sequences for Rapid and Efficient Intracellular Protein Transport at Nanomolar Concentrations.
Oh JH; Chong SE; Nam S; Hyun S; Choi S; Gye H; Jang S; Jang J; Hwang SW; Yu J; Lee Y
Adv Sci (Weinh); 2018 Aug; 5(8):1800240. PubMed ID: 30128238
[TBL] [Abstract][Full Text] [Related]
48. Daphneodorins A-C, Anti-HIV Gnidimacrin Related Macrocyclic Daphnane Orthoesters from
Otsuki K; Li W; Asada Y; Chen CH; Lee KH; Koike K
Org Lett; 2020 Jan; 22(1):11-15. PubMed ID: 31680527
[TBL] [Abstract][Full Text] [Related]
49. HIV-1 capsid assembly inhibitor (CAI) peptide: structural preferences and delivery into human embryonic lung cells and lymphocytes.
Braun K; Frank M; Pipkorn R; Reed J; Spring H; Debus J; Didinger B; von der Lieth CW; Wiessler M; Waldeck W
Int J Med Sci; 2008 Jul; 5(5):230-9. PubMed ID: 18695744
[TBL] [Abstract][Full Text] [Related]
50. Development of anti-HIV peptides based on a viral capsid protein.
Mizuguchi T; Ohashi N; Matsumoto D; Hashimoto C; Nomura W; Yamamoto N; Murakami T; Tamamura H
Biopolymers; 2017 Jan; 108(1):. PubMed ID: 27428649
[TBL] [Abstract][Full Text] [Related]
51. The structure-activity profile of mercaptobenzamides' anti-HIV activity suggests that thermodynamics of metabolism is more important than binding affinity to the target.
Nikolayevskiy H; Robello M; Scerba MT; Pasternak EH; Saha M; Hartman TL; Buchholz CA; Buckheit RW; Durell SR; Appella DH
Eur J Med Chem; 2019 Sep; 178():818-837. PubMed ID: 31252286
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of HIV infection by caerin 1 antimicrobial peptides.
VanCompernolle S; Smith PB; Bowie JH; Tyler MJ; Unutmaz D; Rollins-Smith LA
Peptides; 2015 Sep; 71():296-303. PubMed ID: 26026377
[TBL] [Abstract][Full Text] [Related]
53. Apoptosis inducing, conformationally constrained, dimeric peptide analogs of KLA with submicromolar cell penetrating abilities.
Hyun S; Lee S; Kim S; Jang S; Yu J; Lee Y
Biomacromolecules; 2014 Oct; 15(10):3746-52. PubMed ID: 25188534
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomes.
Aneja R; Grigoletto A; Nangarlia A; Rashad AA; Wrenn S; Jacobson JM; Pasut G; Chaiken I
J Pept Sci; 2019 Apr; 25(4):e3155. PubMed ID: 30809901
[TBL] [Abstract][Full Text] [Related]
55. Photoswitching of Cell Penetration of Amphipathic Peptides by Control of α-Helical Conformation.
Kim GC; Ahn JH; Oh JH; Nam S; Hyun S; Yu J; Lee Y
Biomacromolecules; 2018 Jul; 19(7):2863-2869. PubMed ID: 29856603
[TBL] [Abstract][Full Text] [Related]
56. Design and Optimization of an α-Helical Bundle Dimer Cell-Penetrating Peptide for
Hyun S; Kim D; Cho J; Jeong D; Chung DH; Yu J
Bioconjug Chem; 2022 Dec; 33(12):2420-2427. PubMed ID: 36446084
[TBL] [Abstract][Full Text] [Related]
57. α-Aminoisobutyric acid incorporation induces cell permeability and antiviral activity of HIV-1 major homology region fragments.
Lampel A; Elis E; Guterman T; Shapira S; Marco P; Bacharach E; Gazit E
Chem Commun (Camb); 2015 Aug; 51(62):12349-52. PubMed ID: 26121332
[TBL] [Abstract][Full Text] [Related]
58. A dimeric α-helical cell penetrating peptide mounted with an HER2-selective affibody.
Chong SE; Lee D; Oh JH; Kang S; Choi S; Nam SH; Yu J; Koo H; Lee Y
Biomater Sci; 2021 Nov; 9(23):7826-7831. PubMed ID: 34812802
[TBL] [Abstract][Full Text] [Related]
59. Novel structures of self-associating stapled peptides.
Bhattacharya S; Zhang H; Cowburn D; Debnath AK
Biopolymers; 2012 May; 97(5):253-64. PubMed ID: 22170623
[TBL] [Abstract][Full Text] [Related]
60. Intracellular delivery of immunoglobulin G at nanomolar concentrations with domain Z-fused multimeric α-helical cell penetrating peptides.
Chong SE; Oh JH; Min K; Park S; Choi S; Ahn JH; Chun D; Lee HH; Yu J; Lee Y
J Control Release; 2021 Feb; 330():161-172. PubMed ID: 33340565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
